Hatim Husain

7.4k total citations · 1 hit paper
72 papers, 2.7k citations indexed

About

Hatim Husain is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Hatim Husain has authored 72 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pulmonary and Respiratory Medicine, 41 papers in Oncology and 31 papers in Cancer Research. Recurrent topics in Hatim Husain's work include Lung Cancer Treatments and Mutations (45 papers), Cancer Genomics and Diagnostics (30 papers) and Lung Cancer Research Studies (13 papers). Hatim Husain is often cited by papers focused on Lung Cancer Treatments and Mutations (45 papers), Cancer Genomics and Diagnostics (30 papers) and Lung Cancer Research Studies (13 papers). Hatim Husain collaborates with scholars based in United States, China and Netherlands. Hatim Husain's co-authors include Brian Woodward, Razelle Kurzrock, Scott M. Lippman, Ajaz Bulbul, Geoffrey R. Oxnard, Victor E. Velculescu, Yuebi Hu, Cloud P. Paweletz, Amanda J. Redig and Philip Tracy and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

Hatim Husain

66 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assessment of Resistance Mechanisms and Clinical Implications in Patients WithEGFRT790M–Positive Lung Cancer and Acquired Resistance to Osimertinib

2018 513 citations Geoffrey R. Oxnard, Hatim Husain et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hatim Husain United States	25	1.4k	1.4k	1.2k	1.0k	406	72	2.7k
Ernest Nadal Spain	34	1.8k 1.3×	1.8k 1.3×	815 0.7×	1.5k 1.5×	228 0.6×	169	3.6k
Tina Cascone United States	30	1.6k 1.1×	1.8k 1.3×	684 0.6×	1.4k 1.4×	199 0.5×	104	3.4k
Judy Dering United States	23	1.3k 0.9×	2.2k 1.6×	902 0.8×	1.5k 1.5×	225 0.6×	41	3.6k
Mónica Arnedos France	25	1.0k 0.7×	1.6k 1.2×	1.2k 1.0×	1.4k 1.4×	293 0.7×	90	3.1k
Ferdinandos Skoulidis United States	22	1.4k 0.9×	1.8k 1.3×	729 0.6×	1.4k 1.4×	198 0.5×	73	3.1k
Santiago Viteri Spain	31	2.1k 1.5×	2.1k 1.5×	903 0.8×	1.3k 1.3×	324 0.8×	169	3.4k
Mónica V. Estrada United States	16	677 0.5×	1.4k 1.0×	925 0.8×	1.3k 1.3×	173 0.4×	25	2.5k
Elin Borgen Norway	31	756 0.5×	2.3k 1.6×	1.8k 1.6×	950 0.9×	326 0.8×	88	3.3k
Dorthe Grabau Sweden	28	510 0.4×	1.5k 1.1×	1.6k 1.4×	1.3k 1.3×	380 0.9×	57	3.0k
Florence Lerebours France	29	692 0.5×	1.4k 1.0×	1.2k 1.0×	915 0.9×	304 0.7×	97	2.6k

Countries citing papers authored by Hatim Husain

Since Specialization

Citations

This map shows the geographic impact of Hatim Husain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hatim Husain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hatim Husain more than expected).

Fields of papers citing papers by Hatim Husain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hatim Husain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hatim Husain. The network helps show where Hatim Husain may publish in the future.

Co-authorship network of co-authors of Hatim Husain

This figure shows the co-authorship network connecting the top 25 collaborators of Hatim Husain. A scholar is included among the top collaborators of Hatim Husain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hatim Husain. Hatim Husain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ye, Patrick, et al.. (2025). Molecular counting enables accurate and precise quantification of methylated ctDNA for tumor-naive cancer therapy response monitoring. Scientific Reports. 15(1). 5869–5869. 1 indexed citations

Redman, Mary W., Hatim Husain, Karen L. Reckamp, et al.. (2024). Lung-MAP S1800D: A phase II/III study of N-803 (ALT-803) plus pembrolizumab versus standard of care in participants with stage IV or recurrent non-small cell lung cancer (NSCLC) previously treated with anti-PD-1 or anti-PD-L1 therapy.. Journal of Clinical Oncology. 42(16_suppl). 2619–2619. 2 indexed citations

Luo, Jia, Narjust Florez, Yanyan Lou, et al.. (2024). Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With KRAS ^G12C -Mutated Non–Small Cell Lung Cancer: A Case Series and Literature Review. JCO Precision Oncology. 8(8). e2300644–e2300644. 3 indexed citations

Cho, Byoung Chul, Grace K. Dy, Tae Min Kim, et al.. (2023). PP.42 Phase 1 Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced NSCLC. Journal of Thoracic Oncology. 18(3). S25–S25. 1 indexed citations

Husain, Hatim, Dean C. Pavlick, Bernard J. Fendler, et al.. (2022). Tumor Fraction Correlates With Detection of Actionable Variants Across > 23,000 Circulating Tumor DNA Samples. JCO Precision Oncology. 6(6). e2200261–e2200261. 58 indexed citations

Stolpe, Anja van de, Wim Verhaegh, Jean‐Yves Blay, et al.. (2021). RNA Based Approaches to Profile Oncogenic Pathways From Low Quantity Samples to Drive Precision Oncology Strategies. Frontiers in Genetics. 11. 598118–598118. 18 indexed citations

Roosan, Moom R., Isa Mambetsariev, Rebecca Pharaon, et al.. (2021). Usefulness of Circulating Tumor DNA in Identifying Somatic Mutations and Tracking Tumor Evolution in Patients With Non-small Cell Lung Cancer. CHEST Journal. 160(3). 1095–1107. 27 indexed citations

Bulbul, Ajaz, John Paul Shen, Brian Woodward, et al.. (2019). Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer. Cancer Research. 79(4). 689–698. 164 indexed citations

Wang, Yan, Chuanhua Zhao, Lianpeng Chang, et al.. (2019). Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer. EBioMedicine. 43. 261–269. 62 indexed citations

10.

Ma, Fei, Yanfang Guan, Zongbi Yi, et al.. (2019). Assessing tumor heterogeneity using ctDNA to predict and monitor therapeutic response in metastatic breast cancer. International Journal of Cancer. 146(5). 1359–1368. 63 indexed citations

11.

Phallen, Jillian, Alessandro Leal, Brian Woodward, et al.. (2018). Early Noninvasive Detection of Response to Targeted Therapy in Non–Small Cell Lung Cancer. Cancer Research. 79(6). 1204–1213. 73 indexed citations

12.

Schwaederlé, Maria, Sandip Pravin Patel, Hatim Husain, et al.. (2017). Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma. Clinical Cancer Research. 23(17). 5101–5111. 118 indexed citations

13.

Husain, Hatim, Nam Q. Bui, German G. Gomez, et al.. (2017). Cell-Free DNA from Ascites and Pleural Effusions: Molecular Insights into Genomic Aberrations and Disease Biology. Molecular Cancer Therapeutics. 16(5). 948–955. 76 indexed citations

14.

Husain, Hatim, Vladislava O. Melnikova, Karena Kosco, et al.. (2017). Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine. Clinical Cancer Research. 23(16). 4716–4723. 106 indexed citations

15.

Yeung, Kay T., et al.. (2017). Circulating Tumor DNA for Mutation Detection and Identification of Mechanisms of Resistance in Non-Small Cell Lung Cancer. Molecular Diagnosis & Therapy. 21(4). 375–384. 10 indexed citations

16.

Nemunaitis, John, Hossein Borghaei, Wallace Akerley, et al.. (2017). P2.06-014 Phase 2 Study of Glesatinib or Sitravatinib with Nivolumab in Non-Small Cell Lung Cancer (NSCLC) after Checkpoint Inhibitor Therapy. Journal of Thoracic Oncology. 12(1). S1078–S1078. 3 indexed citations

17.

Schwaederlé, Maria, Hatim Husain, Paul T. Fanta, et al.. (2016). Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients. Clinical Cancer Research. 22(22). 5497–5505. 102 indexed citations

18.

Husain, Hatim, et al.. (2015). Detection of EGFR T790M Mutation in Urinary Circulating Tumor Dna From Metastatic Non-Small Cell Lung Cancer Patients. Annals of Oncology. 26. i10–i10. 5 indexed citations

19.

Seguin, Laetitia, Shumei Kato, Aleksandra Franovic, et al.. (2014). An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition. Nature Cell Biology. 16(5). 457–468. 298 indexed citations

20.

Husain, Hatim, Amanda Psyrri, Ana Marković, et al.. (2012). Nuclear epidermal growth factor receptor and p16 expression in head and neck squamous cell carcinoma. The Laryngoscope. 122(12). 2762–2768. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact